International Conference on Hematology, Immunology and Transfusion Medicine

  01 May 2025 - 02 May 2025

   Austin, USA

conference-img

International Conference on Hematology, Immunology and Transfusion Medicine

01 May 2025

 - 

02 May 2025

Austin, USA



The upcoming (ICHITM-25) at Austin, USA has been organized on 1st - 2nd May 2025 and scheduled to alleviate this exact challenge by serving as a focal point for reseachers in the discipline of Hematology, Immunology and Transfusion Medicine from the world over to gather together, learn from one another, impart and propagate their expertise, and put in place policies and mechanisms that will safeguard the stedfast growth and advancement of Hematology, Immunology and Transfusion Medicine .

participants of this event will be privileged with numerous opportunities to ensure their own personal advancement - be it in their studies, research work, career, or entrepreneurial endeavors.

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

2.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

3.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

4.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

5.

A new blood test greatly increases the ability to detect cancer.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot